BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7636535)

  • 1. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
    Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
    J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
    Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
    Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anti-tumor effect of 13-cRA and IFN-alpha/beta in mouse renal cell carcinoma.
    Taguchi I; Hara I; Gohji K; Arakawa S; Kamidono S
    Int J Oncol; 1998 Jul; 13(1):145-9. PubMed ID: 9625816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
    Stadler WM; Kuzel T; Dumas M; Vogelzang NJ
    J Clin Oncol; 1998 May; 16(5):1820-5. PubMed ID: 9586896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma.
    Casali A; Sega FM; Casali M; Serrone L; Terzoli E
    J Exp Clin Cancer Res; 1998 Jun; 17(2):227-9. PubMed ID: 9700585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
    Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
    Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
    Ryu S; Kim OB; Kim SH; He SQ; Kim JH
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
    Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
    Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
    Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer.
    Gause BL; Sznol M; Kopp WC; Janik JE; Smith JW; Steis RG; Urba WJ; Sharfman W; Fenton RG; Creekmore SP; Holmlund J; Conlon KC; VanderMolen LA; Longo DL
    J Clin Oncol; 1996 Aug; 14(8):2234-41. PubMed ID: 8708712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
    Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
    Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
    Kinney P; Triozzi P; Young D; Drago J; Behrens B; Wise H; Rinehart JJ
    J Clin Oncol; 1990 May; 8(5):881-5. PubMed ID: 2332772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma.
    Buer J; Probst M; Ganser A; Atzpodien J
    J Clin Oncol; 1995 Oct; 13(10):2679-80. PubMed ID: 7595723
    [No Abstract]   [Full Text] [Related]  

  • 14. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
    Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
    J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
    Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
    J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas.
    Geng Y; Biffi A; Engelstein D; Ronch E; Faustini M; Lai HK; Albino AP; Di Fronzo G; Nanus DM
    Anticancer Res; 1998; 18(1A):1-7. PubMed ID: 9568047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid inhibits the growth of human myeloma cells in vitro.
    Palumbo A; Battaglio S; Napoli P; Bruno B; Omedè P; Boccadoro M; Pileri A
    Br J Haematol; 1995 Mar; 89(3):555-60. PubMed ID: 7734354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma.
    Ilson DH; Motzer RJ; Kradin RL; Vogelzang NJ; Bajorin DF; Scher HI; Nanus D; O'Moore P; Marathias K; Bosl GJ
    J Clin Oncol; 1992 Jul; 10(7):1124-30. PubMed ID: 1607918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
    Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
    Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein.
    Nanus DM; Pfeffer LM; Bander NH; Bahri S; Albino AP
    Cancer Res; 1990 Jul; 50(14):4190-4. PubMed ID: 2364374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.